CAS: 211364-06-6
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | AT 130 REF: 4Z-B-118003CAS: 211364-06-6 | - - - | A consultar | Jue 16 May 24 |
 | AT-130 REF: TM-T26674CAS: 211364-06-6 | 98.62% | 72,00 €~922,00 € | Jue 16 May 24 |
 | AT-130 REF: 3D-LIA36406CAS: 211364-06-6 | Min. 95% | A consultar | Jue 20 Jun 24 |
Ref: 4Z-B-118003
| 10mg | A consultar | |
| 25mg | A consultar | |
| 50mg | A consultar | |
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Jueves 16 de Mayo de 2024
AT-130
CAS:211364-06-6
AT-130 is a HBV virus inhibitor with improved potency (IC50 = 0.13 μM) and reduced …
Fórmula:
C22H22BrN3O5
Pureza:
98.62%
Forma y color:
Solid
Peso molecular:
488.33
Ref: TM-T26674
| 1mg | 72,00 € | |
| 5mg | 158,00 € | |
| 10mg | 292,00 € | |
| 25mg | 464,00 € | |
| 50mg | 672,00 € | |
| 100mg | 922,00 € | |
| 1ml*10 (DMSO) | 171,00 € |
Entrega estimada en Estados Unidos, el Jueves 16 de Mayo de 2024
AT-130
CAS:211364-06-6
AT-130 is a peptide that binds to the CCR5 receptor, which is found on the …
Fórmula:
C22H22BrN3O5
Pureza:
Min. 95%
Peso molecular:
488.3 g/mol
Ref: 3D-LIA36406
| 1mg | A consultar | |
| 5mg | A consultar | |
| 10mg | A consultar | |
| 25mg | A consultar | |
| 50mg | A consultar |
Entrega estimada en Estados Unidos, el Jueves 20 de Junio de 2024
